The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization dedicated to accelerating the development of new and improved treatments for drug-resistant infections. By collaborating with various partners, GARDP aims to ensure sustainable access to these treatments while promoting responsible use and affordability for all individuals in need. The organization focuses on uniting public and private sectors to tackle the public health challenges posed by antibiotic resistance, particularly through initiatives like SECURE, which seeks to enhance access to effective antibiotics in low- and middle-income countries.